首页> 外文OA文献 >PUK11 COST-MINIMIZATION ANALYSIS: MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING

【2h】

PUK11 COST-MINIMIZATION ANALYSIS: MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING

机译：PUK11成本最小化分析：MIRCERA（甲氧基聚乙烯乙二醇-表皮素测试版）VS。在波兰，患有慢性肾脏病（CKD）的患者中未接受ARANESP（DARBEPOETIN ALFA）的治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kawalec P; Kuzma J; Szkultecka-Debek M; Russel-Szymczyk M; Slizien-Debska A; Malyszko J; Durlik M;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. [J] . Carrera F, Lok CE, de Francisco A, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2010,第12期

机译：甲氧聚乙二醇乙二醇-依泊汀β与达比泊汀α每月给予血液透析患者的肾性贫血的维持治疗：一项随机对照试验。
2. Methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa for anemia in non-dialysis-dependent CKD: a systematic review [J] . Alsalimy Noor, Awaisu Ahmed International journal of clinical pharmacy. . 2014,第6期

机译：甲氧聚乙二醇-表皮素β与达比泊汀α治疗非透析依赖性CKD贫血：系统评价
3. An open-label, multicenter, multiple-dose study to determine the optimum starting dose of CERA (continuous erythropoietin receptor activator - methoxy polyethylene glycol-epoetin beta) for maintenance treatment of anemia in pediatric patients with chronic kidney disease (CKD) on hemodialysis (HD) (NH19707, NCT00717366) [J] . Fischbach M., Wuehl E., Meyer-reigner S., Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2016,第10期

机译：一项开放性，多中心，多剂量研究，用于确定CERA（连续性促红细胞生成素受体激活剂-甲氧基聚乙二醇-表皮素β）的最佳起始剂量，用于维持治疗慢性肾脏病（CKD）的小儿血液透析患者的贫血（ HD）（NH19707，NCT00717366）
4. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial [O] . Fernando Carrera, Charmaine E. Lok, Angel de Francisco, -1

机译：甲氧聚乙二醇-epoetinβ与达比泊汀阿尔法每月给予血液透析患者的肾性贫血的维持治疗：一项随机对照试验
5. Anemia response to Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) versus Epoetin Alfa (Eprex) in patients with chronic Kidney disease on Hemodialysis [O] . Alaa K Dhayef 2017

机译：血液透析慢性肾病患者对甲氧基聚乙二醇-epoetinβ（Mircera）对慢性肾病患者的反应

PUK11 COST-MINIMIZATION ANALYSIS: MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING

著录项

相似文献

相关主题

期刊订阅